Sask. lab says its COVID-19 vaccine candidate has been found safe, issues open call for volunteers to receive it
The COVID-19 vaccine developed by the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan is safe, the lab announced Wednesday.
The most common reactions from the Phase 1 clinical trial for the vaccine, named COVAC-2, were a headache and mild injection site pain, which VIDO says are common after most immunizations.
In addition, even the lowest vaccine dose significantly increased the participants’ antibody levels, including neutralizing antibodies against SARS-CoV-2, VIDO says.
“The data continues to demonstrate the safety of our subunit vaccine COVAC-2,” Dr. Volker Gerdts, director and CEO of VIDO, said in a news release.
“We are encouraged by the vaccine’s ability to generate a significant immune response, even at the lowest dose tested.”
Subunit vaccines such as COVAC-2 contain purified viral proteins that are not infectious and the technology offers a history of safety and ease of storage and transport, VIDO says.
Participants continue to be recruited for the clinical trial in Halifax and a new clinical trial site will also open in Saskatoon later this summer.
Those 18 years and older who have not been infected with COVID-19 or received an authorized COVID-19 vaccine are eligible to volunteer.
They can contact the Clinical Trial Support Unit at ctsu@usask.ca or 306-978-8300.
CTVNews.ca Top Stories
Doctors say capital gains tax changes will jeopardize their retirement. Is that true?
The Canadian Medical Association asserts the Liberals' proposed changes to capital gains taxation will put doctors' retirement savings in jeopardy, but some financial experts insist incorporated professionals are not as doomed as they say they are.
Something in the water? Canadian family latest to spot elusive 'Loch Ness Monster'
For centuries, people have wondered what, if anything, might be lurking beneath the surface of Loch Ness in Scotland. When Canadian couple Parry Malm and Shannon Wiseman visited the Scottish highlands earlier this month with their two children, they didn’t expect to become part of the mystery.
Fair in Ontario, flurries in Labrador: Weather systems make for an erratic spring
It's no secret that spring can be a tumultuous time for Canadian weather, and as an unseasonably mild El Nino winter gives way to summer, there's bound to be a few swings in temperature that seem out of the ordinary. From Ontario to the Atlantic, though, this week is about to feel a little erratic.
What do weight loss drugs mean for a diet industry built on eating less and exercising more?
Recent injected drugs like Wegovy and its predecessor, the diabetes medication Ozempic, are reshaping the health and fitness industries.
He replaced Mickey Mantle. Now baseball's oldest living major leaguer is turning 100
The oldest living former major leaguer, Art Schallock turns 100 on Thursday and is being celebrated in the Bay Area and beyond as the milestone approaches.
What a urologist wants you to know about male infertility
When opposite sex couples are trying and failing to get pregnant, the attention often focuses on the woman. That’s not always the case.
'It was instant karma': Viral video captures failed theft attempt in Nanaimo, B.C.
Mounties in Nanaimo, B.C., say two late-night revellers are lucky their allegedly drunken antics weren't reported to police after security cameras captured the men trying to steal a heavy sign from a downtown business.
Bank of Canada officials split on when to start cutting interest rates
Members of the Bank of Canada's governing council were split on how long the central bank should wait before it starts cutting interest rates when they met earlier this month.
Made-in-Newfoundland vodka claims top prize at worldwide competition
A Newfoundland-made vodka has been named one of the world’s best by judges at this year’s World Vodka Awards.